Title: Tria GS, et al. Discovery of LSZ102, a Potent, Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer. J Med Chem. 2018 Apr 12;61(7):2837-2864.
1532533-69-9 | Umbralisib R-enantiomer | AA01EO78 | MFCD30534428
124900-72-7 | YM17E | AA01EOES | MFCD00903735
2070015-22-2 | ILK-IN-2 | AA01EOLJ | MFCD29924730
1092970-12-1 | Morphothiadin | AA01EOPR | MFCD30738320
1630023-01-6 | (2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-((5-(3-(2,2,3,3-tetramethylcyclopropane-1-carbonyl)-1H-indol-1-yl)pentyl)oxy)tetrahydro-2H-pyran-2-carboxylicacid | AA01EOY4
1542066-74-9 | 4-(4-bromophenyl)-1-[(4-fluorophenyl)methyl]-4,5-dihydro-5-[3-(1H-imidazol-1-yl)propyl]-3-phenyl-pyrrolo[3,4-c]pyrazol-6(1H)-one | AA01EP8E
1415252-61-7 | 4'-[[5-[[[(1S)-1-[4-(1,1-dimethylethyl)phenyl]ethyl]amino]carbonyl]-2,3-dimethyl-1H-indol-1-yl]methyl]-[1,1'-biphenyl]-2-carboxylicacid | AA01EPGT | MFCD31697729
460331-61-7 | 2-furanyl[4-(5,6,7,8-tetrahydro-2-methyl[1]benzothieno[2,3-d]pyrimidin-4-yl)-1-piperazinyl]-methanone | AA01EPLU | MFCD03127624
142828-42-0 | 4Z,7Z,10Z,13Z,16Z-docosapentaenoicacid,ethylester | AA01EPSP
847674-32-2 | 6α-chloro-17β-hydroxy-androst-4-en-3-one | AA01EQ1J
